A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2002
10/23/2002	EP1250161A2 Polymer blends as biodegradable matrices for preparing biocomposites
10/23/2002	EP1250155A1 Angiogenesis and vascular permeability modulators and inhibitors
10/23/2002	EP1250151A1 Composition consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis
10/23/2002	EP1250144A1 Vegetable oil for preparing a composition inhibiting 5$g(a)- reductase activity
10/23/2002	EP1250143A2 Reduction in bacterial colonization by administering bacteriophage compositions
10/23/2002	EP1250142A1 Multivalent electron active compositions and methods of making and using same
10/23/2002	EP1250140A2 Combinations of a receptor tyrosine kinase inhibitor with alpha1-acidic glycoprotein binding compound
10/23/2002	EP1250137A2 Jak/stat pathway inhibitors and the uses thereof
10/23/2002	EP1250134A1 Compositions for the prevention of diaper dermatitis
10/23/2002	EP1250124A2 Slimming cosmetic composition comprising as active agent a plant extract containing a plant natriuretic peptide (pnp)
10/23/2002	EP1250116A1 Pharmaceutical and cosmetic carrier or composition for topical application
10/23/2002	EP1250053A2 Method for produce sanitation using bacteriophages
10/23/2002	EP1250050A2 Method and device for sanitation using bacteriophages
10/23/2002	EP1159966B1 Composition for the treatment of psoriasis
10/23/2002	EP1009380B1 Method for preparing pharmaceutical formulations
10/23/2002	EP0925303B1 Phosphinic acid amides as matrix metalloprotease inhibitors
10/23/2002	EP0923561B1 Heterocyclic metalloprotease inhibitors
10/23/2002	EP0772446B1 Anti-adhesion agent
10/23/2002	EP0767170B1 Novel 4,6-diarylpyrimidine derivatives and salts thereof
10/23/2002	EP0750510B1 Anti-acne skin treatment composition
10/23/2002	CN1376165A Materials and methods for inhibition of Lg E production
10/23/2002	CN1376157A Triazolopurine derivatives, drug compositions containing the same and adenosine A3 receptor affinitive agents
10/23/2002	CN1376156A Benzodiazepin derivatives, the production and use thereof
10/23/2002	CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002	CN1376144A Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
10/23/2002	CN1376067A Conditioned cell culture medium compositions and method of use
10/23/2002	CN1376055A Aerosol ointment compositions and method of manufacture
10/23/2002	CN1376043A Drug delivery of phase changing formulation
10/23/2002	CN1375335A Beta signal transduction blocker as a transforming growth factor and its use
10/23/2002	CN1375315A Huoba root capsule for treating intractable verruca vulgaris and condyloma acuminata
10/23/2002	CN1375314A Fermented soybean extracted liquid and composite medicine containing the said liquid
10/23/2002	CN1375313A Recipe and prepn. process of medicine for treating burns and scalds
10/23/2002	CN1375306A Sanhuanggao ointment as externally used medicine for treating burns and scalds
10/23/2002	CN1375298A Pain-relieving notoginseng mixture
10/23/2002	CN1375297A Hircus treating medicament
10/23/2002	CN1375290A Method for releasing L-asorbic substance to dermis layer of skin and composition thereof
10/23/2002	CN1375247A Healthy shoes of konjaku
10/23/2002	CA2383149A1 Process for partially reducing or eliminating the symptoms associated with the release of histamine in the body
10/23/2002	CA2383115A1 Use of an effective amount of at least one ion chelating agent to enhance the tolerance level of sensitive or intolerant skin
10/22/2002	US6469227 Antipruritic patch
10/22/2002	US6469174 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
10/22/2002	US6469162 Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis
10/22/2002	US6469070 Topical medicament comprising phenolic biocide and choline
10/22/2002	US6469066 Treating burns with one or more of acetic acid, vinegar and citric acid for prevention of delayed hyperalgesia
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002	US6469036 Peptidyl heterocyclic ketones useful as tryptase inhibitors
10/22/2002	US6469033 Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
10/22/2002	US6469032 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
10/22/2002	US6469025 For the prophylaxis or treatment of a disease or disorder in a mammal in which the extravasation of leukocytes plays a role; inhibiting the binding of alpha 4 integrins to their ligands
10/22/2002	US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002	US6469018 Compounds
10/22/2002	US6469013 Therapeutic compounds
10/22/2002	US6469004 Benzoheterocycles and their uses as MEK inhibitors
10/22/2002	US6469001 IL-5 inhibiting 6-azauracil derivatives
10/22/2002	US6469000 1,3-diheterocyclic metalloprotease inhibitors
10/22/2002	US6468997 Desmethylolanzapine compositions and methods
10/22/2002	US6468989 Gel compositions containing metronidazole
10/22/2002	US6468977 Compounds useful in treatment treatment of disorder and/or disease caused by activity of enzymes such as human rhinovirus 3c protease, transglutaminase and cathepsins
10/22/2002	US6468974 Oligopeptides that provide desirable in vitro and in vivo growth hormone releasing activity and have at least one other desirable biological activity such as increased retention time
10/22/2002	US6468972 Method to promote, stimulate and/or delay hair loss by a brady kinin antagonist
10/22/2002	US6468960 Therapeutic compositions and methods for enhancing angiogenesis
10/22/2002	US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002	US6468737 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
10/22/2002	US6468551 Cosmetic or dermatological preparations based on emulsifiers which are free from ethylene oxide and propylene oxide, for the preparation of microemulsion gels
10/22/2002	US6468549 Gelling or thickening a cosmetic or dermatological composition
10/22/2002	US6468519 Polyanhydrides with biologically active degradation products
10/22/2002	CA2136614C Nitrous oxide containing dermatological composition
10/20/2002	CA2380211A1 Compositions for controlling microorganisms, comprising primary and secondary esters of polyglycerol in an effective ratio
10/17/2002	WO2002081747A1 Method of examining steroid responsiveness
10/17/2002	WO2002081668A2 Desaturase genes and uses thereof
10/17/2002	WO2002081627A2 Methods of screening and using inhibitors of angiogenesis
10/17/2002	WO2002081536A1 Film-forming composition for topical use and use thereof for delivering active agents
10/17/2002	WO2002081521A2 Osteoprotegerin in milk
10/17/2002	WO2002081508A2 Use of cd25 binding molecules in steroid-resistant patients
10/17/2002	WO2002081499A2 Somatostatin agonists
10/17/2002	WO2002081461A1 Piperazine derivatives as tachykinin antagonists
10/17/2002	WO2002081457A1 `1,4!-diazepane-1-carboxylic acid derivatives process for their preparation and their use as tachykinin antagonists
10/17/2002	WO2002081449A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/17/2002	WO2002081430A2 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
10/17/2002	WO2002081420A1 Cyclooctanone derivative and cyclodecanone derivative, and use thereof
10/17/2002	WO2002081415A2 Method for inhibiting metap2
10/17/2002	WO2002081027A1 An antioxidant composition and a cosmetic or pharmaceutical composition
10/17/2002	WO2002080978A2 Pharmaceutical compositions comprising ascomycin
10/17/2002	WO2002080976A2 Hsa-free formulations of interferon-beta
10/17/2002	WO2002080950A1 Use of an extract of alpinia officinarum rhizomes
10/17/2002	WO2002080949A1 Use of extracts of the plant litchi chinensis sonn.
10/17/2002	WO2002080941A1 Compositions for preparing external carbon dioxide agents
10/17/2002	WO2002080932A1 Methods of treating acne
10/17/2002	WO2002080930A1 Intermittent lowering of levels of cortisol and other adrenalhormones as treatment of clinical conditions associated with abnormal concentrations of such hormones in man and animals
10/17/2002	WO2002080926A1 Pyrazolopyrimidines as therapeutic agents
10/17/2002	WO2002080923A1 Substances for use in therapy of diseases that are caused by highly proliferative cells
10/17/2002	WO2002080914A2 Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments
10/17/2002	WO2002080911A2 Use of substituted imidazo[1,2-a]-pyridine-3-yl-amide and imidazo[1,2-a]-pyridine-3-yl-amine compounds as medicaments for the treatment of neurodegenerative diseases
10/17/2002	WO2002080896A1 Uses of benzylideneamino guanidines as ligands to the melanocortiin receptors
10/17/2002	WO2002080887A2 Timed pulse release composition
10/17/2002	WO2002080882A1 Skin care cream containing omega-3
10/17/2002	WO2002080858A2 Use of kpv tripeptide for dermatological disorders
10/17/2002	WO2002080842A2 Medicament and method for diagnosing an autoimmune condition_in particular psoriasis
10/17/2002	WO2002080754A2 Methods for using annexin for detecting cell death in vivo and treating associated conditions

1 ... 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 ... 1065